Literature DB >> 3488848

Pertussis: epidemiology and control.

A S Muller, J Leeuwenburg, D S Pratt.   

Abstract

Keywords:  Age Distribution; Age Factors; Bacterial And Fungal Diseases; Communicable Disease Control; Communicable Diseases--prevention and control; Data Analysis; Delivery Of Health Care; Demographic Factors; Diseases; Epidemiologic Methods; Examinations And Diagnoses; Health; Health Services; Immunization; Incidence; Infections; Measurement; Medicine; Mortality; Population; Population Characteristics; Population Dynamics; Preventive Medicine; Primary Health Care; Public Health; Research Methodology; Sex Distribution; Sex Factors; Vaccination--administraction and dosage

Mesh：

Substances：

Year:  1986        PMID： 3488848      PMCID： PMC2490947     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  41 in total

1.  Large-scale field trials of active immunizing agents; with special reference to vaccination against pertussis.

Authors:  W C COCKBURN
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

2.  Machakos project studies. Agents affecting health of mother and child in a rural area of Kenya. V. Pertussis sentypes in Kenyan children 1974--1975.

Authors:  S Patel; G Schoone; G S Ligthart; H Gikken; N W Preston
Journal:  Trop Geogr Med       Date:  1978-03

3.  Generalized type 5 adenovirus infection associated with the pertussis syndrome.

Authors:  A M Collier; J D Connor; W R Irving
Journal:  J Pediatr       Date:  1966-12       Impact factor: 4.406

4.  Agglutinin response to pertussis vaccine. I. Effect of dosage and interval.

Authors:  J Wilkins; F F Williams; P F Wehrle; B Portnoy
Journal:  J Pediatr       Date:  1971-08       Impact factor: 4.406

5.  Change in serotype of pertussis infection in Britain.

Authors:  N W Preston
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

6.  Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs.

Authors:  A R Hinman; J P Koplan
Journal:  JAMA       Date:  1984-06-15       Impact factor: 56.272

7.  Machakos project studies. Agents affecting health of mother and child in a rural area of Kenya. I. Introduction: study design and methodology.

Authors:  A S Muller; J H Ouma; F M Mburu; P G Blok; J W Kleevens
Journal:  Trop Geogr Med       Date:  1977-09

8.  Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA).

Authors:  M K Viljanen; O Ruuskanen; C Granberg; T T Salmi
Journal:  Scand J Infect Dis       Date:  1982

9.  Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

Authors:  D G Burstyn; L J Baraff; M S Peppler; R D Leake; J St Geme; C R Manclark
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  [Preliminary findings with oral whooping cough vaccination in young infants (author's transl)].

Authors:  H Maurer; K H Höfler; W Hilbe; E G Huber
Journal:  Wien Klin Wochenschr       Date:  1979-11-09       Impact factor: 1.704
View more
  11 in total

1.  Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.

Authors:  G R Zealey; S M Loosmore; R K Yacoob; S A Cockle; A B Herbert; L D Miller; N J Mackay; M H Klein
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

2.  Management of people exposed to pertussis and control of pertussis outbreaks.

Authors: 
Journal:  CMAJ       Date:  1990-10-15       Impact factor: 8.262

Review 3.  Routine childhood immunisation: is it worth it?

Authors:  S P Conway; B Leese
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

4.  Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes.

Authors:  A A Weiss; A R Melton; K E Walker; C Andraos-Selim; J J Meidl
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.

Authors:  M A Schmidt; W Schmidt
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin.

Authors:  W Schmidt; M A Schmidt
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 7.  Pertussis vaccines--1993.

Authors:  H J Schmitt; S Wagner
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

8.  Seroepidemiology of pertussis infection in an urban childhood population in Cameroon.

Authors:  T Stroffolini; A Giammanco; A Chiarini; S Taormina; A Sarzana; G Mazza; M Maggio; M Chiaramonte; T Ngatchu; D Lantum
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

9.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

Authors:  A Podda; L Nencioni; M T De Magistris; A Di Tommaso; P Bossù; S Nuti; P Pileri; S Peppoloni; M Bugnoli; P Ruggiero
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.